Deflazacort's Role in Managing Duchenne Muscular Dystrophy
Deflazacort offers hope for those with Duchenne Muscular Dystrophy (DMD), a genetic disorder that affects muscle function. Known for its anti-inflammatory properties, this corticosteroid is highlighted for its ability to slow disease progression and enhance quality of life. The article delves into its benefits, application tips, and the impact on patients' overall wellbeing. This exploration aids patients and caregivers alike in making informed decisions regarding DMD management.